Development of malignant hyperthermia post-cardiopulmonary bypass during surgery for mitral valve replacement.
Department of Anesthesiology, SUNY Upstate Medical Center, Syracuse, NY, USA.
Andy B
AB
Pandya
Colleen E
CE
O'Leary
D000328:Adult; D000768:Anesthesia, General / Q000009:adverse effects; D018685:Anesthetics, Inhalation / Q000009:adverse effects; D018686:Anesthetics, Intravenous / Q000009:adverse effects; D002315:Cardiopulmonary Bypass; D004452:Echocardiography; D005260:Female; D005283:Fentanyl / Q000009:adverse effects; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D007530:Isoflurane / Q000009:adverse effects; D008305:Malignant Hyperthermia / Q000209:etiology*; D008874:Midazolam / Q000009:adverse effects; D008944:Mitral Valve Insufficiency / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000601:surgery*; D008946:Mitral Valve Stenosis / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000601:surgery*; D009119:Muscle Contraction / Q000187:drug effects; D011183:Postoperative Complications / Q000139:chemically induced / Q000209:etiology*; D013318:Stroke Volume / Q000502:physiology
D018685:Anesthetics, Inhalation; D018686:Anesthetics, Intravenous; D007530:Isoflurane; D008874:Midazolam; D005283:Fentanyl